[1] Warkad S D, Song K S, Pal D, et al. Developments in the HCV screening technologies based on the detection of antigens and antibodies[J]. Sensors (Basel), 2019, 19(19):4257. [2] Blumberg B S, Alter H J, Visnich S. A “new” antigen in leukemia sera [J]. JAMA, 1965, 191: 541-546. [3] Alter H J, Holland P V, Purcell R H, et al. Posttransfu- sion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors [J]. Ann Intern Med, 1972, 77(5): 691-699. [4] Feinstone S M K A, Purcell R H. Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness [J]. Science, 1973, 182: 1026-1028. [5] Feinstone S M, Kapikian A Z, Purcell R H, et al. Transfusion-associated hepatitis not due to viral hepatitis type A or B [J]. N Engl J Med, 1975, 292(15): 767-770. [6] Alter H J, Purcell R H, Holland P V, et al. Transmissible agent in non-A, non-B hepatitis [J]. Lancet, 1978, 1(8062): 459-463. [7] Choo Q L, Kuo G, Weiner A J, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [J]. Science, 1989, 244(4902): 359-362. [8] Kolykhalov A A, Agapov E V, Blight K J, et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA [J]. Science, 1997, 277(5325): 570-574. [9] Lohmann V, Korner F, Koch J, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line [J]. Science, 1999, 285(5424): 110-113. |